A new observational study compared the risk for severe gastrointestinal adverse events across dulaglutide, semaglutide, and ...

Semaglutide appears to be protective against heart attacks and other cardiac events regardless of weight loss, research has ...

Semaglutide reduces the risk of heart attack, stroke, and other major cardiac events. | Drug Discovery And Development ...

Wegovy-maker Novo Nordisk presented new data on Wednesday showing its experimental weight-loss pill improved blood sugar ...

The Company’s investigational small moleculeglucagon-like peptide-1 (“GLP-1”) receptor agonist (“RA”), BMF-650, demonstrated potent weight loss ...

Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...

The number of medications in development to treat obesity continues to grow, and the drugs can offer health benefits for ...

The cardioprotective effects of semaglutide are independent of baseline adiposity and weight loss, according to a recent study.

Tirzepatide, semaglutide, and liraglutide vs DPP4i were associated with lower risk of alcohol use disorder, especially among men and younger patients.

New clinician-guided program blends medical science, microdosing, and 24/7 support to make advanced weight loss and wellness ...

SmartScripts has faced a welter of lawsuits and been fined for its sale of a counterfeit version of popular weight-loss drug Ozempic.

Some guys are getting this promising new weight loss drug on the grey market. Here's what it does and the risks of taking it ...